@article{article, title = {{The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)ethyl-bisphosphonate), with reduced bone affinity, which is as effective as zoledronate in the treatment of myeloma bone disease in JJN3-NOD/SCID-[gamma] mice}}, publisher = {{Bioscientifica}}, url = {{}}, year = {{2016}}, month = {{4}}, author = {{Lawson M and Chantry A and Paton-Hough J and Evans H and Lath D and Tsoumpra M and Lundy M and Dobson R and Quijano M and Kwaasi A and Dunford J et al}}, doi = {{10.1530/boneabs.5.p128}}, journal = {{Bone Abstracts}}, note = {{Accessed on 2025/04/06}}}